Edoardo Salladini

Edoardo Salladini

External


Publication year:
All
1 - 2 out of 2Page size: 10
  1. 2024
  2. Accepted/In press

    AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications

    Pippione, A. C., Vigato, C., Tucciarello, C., Hussain, Samrina, Salladini, Edoardo, Truong, H. H., Henriksen, N. M., Vanzetti, G., Giordano, G., Zonari, D., Mirza, Osman Asghar, Frydenvang, Karla Andrea, Pignochino, Y., Oliaro-Bosso, S., Boschi, D. & Lolli, M. L., 2024, (Accepted/In press) In: ACS Medicinal Chemistry Letters.

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Published

    Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer

    Pippione, A. C., Kovachka, S., Vigato, C., Bertarini, L., Mannella, I., Sainas, S., Rolando, B., Denasio, E., Piercy-Mycock, H., Romalho, L., Salladini, E., Adinolfi, S., Zonari, D., Peraldo-Neia, C., Chiorino, G., Passoni, A., Mirza, O. A., Frydenvang, K., Pors, K., Lolli, M. L. & 3 others, Spyrakis, F., Oliaro-Bosso, S. & Boschi, D., 2024, In: European Journal of Medicinal Chemistry. 268, 20 p., 116193.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 217982202